Josh Dudman

@dudman.bsky.social

husband, father, neuroscientist, senior group leader at Janelia sending missives to the world in a personal capacity; he|him www.dudmanlab.org https://orcid.org/0000-0002-4436-1057

This shift comes at a large cost to be borne primarily by young investigators at Janelia, at a time when scientific environment is exceptionally uncertain. How innovative it is to repeat, in fish, what was done in flies remains an open question tbd. Not an open question: immediate cost and who pays

The Transmitter @thetransmitter.bsky.social · last mo.

HHMI’s Janelia Research Campus will close two of its programs dedicated to rodent work, @thetransmitter.bsky.social has learned. #neuroskyence By @callimcflurry.bsky.social www.thetransmitter.org/community/ex...

Incredible! Scientists receive a rare standing ovation after announcing that a new treatment can double the survival time for pancreatic cancer, the deadliest cancer which was once considered “undruggable.” When we fund and support science, we can achieve anything! (Video: Dr. Wish Dhillon)

OMB just published 412 pages in the Federal Register (Docket OMB-2026-0034) giving political appointees authority to terminate any NIH grant, override peer review scores, and block you from publishing with federal funds. Comment period closes ~July 13. Thread 🧵

Bild

Posting for Vibhu Sahni: Due to unforeseen circumstances the Burke Neurological Institute will have to terminate its research operations 5/22. There are international postdocs on visas who are looking for new homes. Please reach out to Vibhu if you can help

Scientists just discovered new "controllers" of the brain's most elite security checkpoint. Jiefu Li & team at our Janelia Research Campus have ID'd proteins that help open & close the blood-brain barrier — a step toward treating Alzheimer's, Parkinson's, & more: hhmi.news/4mkrDT2.

Janelia Group Leader Jiefu Li (right) and his team are uncovering how the blood-brain barrier functions.

"Pancreatic cancer mRNA vaccine shows lasting results in an early trial: Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later."

Pancreatic cancer mRNA vaccine shows lasting results in an early trial

Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later.

nbcnews.com

No-cost workshop opportunities for grad students, postdocs, & trainees! Our Janelia Research Campus is accepting applications for 3 specialized, intensive workshops with presentation & networking opportunities. Accommodations, meals, & travel expenses covered: bit.ly/4roghP6. 🧪

3 people gathered around a poster presentation at Janelia's Research Campus